title: Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.
abstract: U-67413B (4-hydroxydipropylaminodihydrophenalene) bound with high affinity to both 5-hydroxytryptamine (HT)1A and D2-dopamine (DA) receptor sites. U-67413B depressed 5-HT and DA cell firing rates and depressed synthesis of both neurotransmitters. The drug depressed mouse body temperatures by an amount similar to that for buspirone, gepirone and ipsapirone, but less than that for 8-hydroxy-N,N-dipropyl-2-aminotetralin. In rats, it produced the 5-HT1A behavioral syndrome. In contrast to 5-HT1A agonists having DA antagonist effects, U-67413B mildly depressed rather than stimulated firing rates of noradrenaline (NA) neurons in the locus ceruleus by a non-alpha-2 receptor mechanism. In behavioral tests designed to measure anxiolytic activities, U-67413B was a slightly more effective anxiolytic than standard 5-HT1A anxiolytics (buspirone, gepirone and ipsapirone). The data are consistent with the hypothesis that effects of 5-HT1A agonists on NA neuron activity are mediated through effects on dopaminergic mechanisms, and that effects on NA neurons could modulate anxiolytic activities of 5-HT1A agonists.
authors.affiliation: Upjohn Company, Kalamazoo, Michigan.
authors.forename: M F
authors.initials: MF
authors.lastname: Piercey
authors.forename: A H
authors.initials: AH
authors.lastname: Tang
authors.forename: R A
authors.initials: RA
authors.lastname: Lahti
authors.forename: P F
authors.initials: PF
authors.lastname: VonVoigtlander
authors.forename: P J
authors.initials: PJ
authors.lastname: Schreur
authors.forename: R B
authors.initials: RB
authors.lastname: McCall
authors.forename: J T
authors.initials: JT
authors.lastname: Lum-Ragan
authors.forename: W E
authors.initials: WE
authors.lastname: Hoffmann
authors.forename: S R
authors.initials: SR
authors.lastname: Franklin
authors.forename: R A
authors.initials: RA
authors.lastname: Code
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003975:Diazepam / Q000494:pharmacology; D015259:Dopamine Agents / Q000494:pharmacology*; D008297:Male; D051379:Mice; D015394:Molecular Structure; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D043803:Phenalenes; D011083:Polycyclic Compounds / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017448:Receptors, Dopamine D2 / Q000187:drug effects; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*
chemical_list: D015259:Dopamine Agents; D043803:Phenalenes; D011083:Polycyclic Compounds; D017448:Receptors, Dopamine D2; D017366:Serotonin Receptor Agonists; C086424:U 67413B; D003975:Diazepam